Your browser doesn't support javascript.
loading
A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder.
Papakostas, G I; Johe, K; Hand, H; Drouillard, A; Russo, P; Kay, G; Kashambwa, R; Hoeppner, B; Flynn, M; Yeung, A; Martinson, M A; Fava, M.
Afiliação
  • Papakostas GI; Massachusetts General Hospital Clinical Trials Network and Institute (MGH CTNI), Boston, MA, USA. gpapakostas@partners.org.
  • Johe K; Neuralstem, Inc, Germantown, MD, USA.
  • Hand H; Neuralstem, Inc, Germantown, MD, USA.
  • Drouillard A; Neuralstem, Inc, Germantown, MD, USA.
  • Russo P; Neuralstem, Inc, Germantown, MD, USA.
  • Kay G; Cognitive Research Corp., Saint Petersburg, Florida, USA.
  • Kashambwa R; Massachusetts General Hospital Clinical Trials Network and Institute (MGH CTNI), Boston, MA, USA.
  • Hoeppner B; Massachusetts General Hospital Clinical Trials Network and Institute (MGH CTNI), Boston, MA, USA.
  • Flynn M; Massachusetts General Hospital Clinical Trials Network and Institute (MGH CTNI), Boston, MA, USA.
  • Yeung A; Massachusetts General Hospital Clinical Trials Network and Institute (MGH CTNI), Boston, MA, USA.
  • Martinson MA; Massachusetts General Hospital Clinical Trials Network and Institute (MGH CTNI), Boston, MA, USA.
  • Fava M; Massachusetts General Hospital Clinical Trials Network and Institute (MGH CTNI), Boston, MA, USA.
Mol Psychiatry ; 25(7): 1569-1579, 2020 07.
Article em En | MEDLINE | ID: mdl-30626911
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Transtorno Depressivo Maior / Aminopiridinas Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Transtorno Depressivo Maior / Aminopiridinas Idioma: En Ano de publicação: 2020 Tipo de documento: Article